Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04095195 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Subjects at Risk of Pancreatic Cancer

Study acronym: IRFARPC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: details revised at 1 of 1 entryv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
Trial Details
NCT Number NCT04095195
Lead Sponsor Associazione Italiana per lo Studio del Pancreas
Conditions
(from sponsor)		 Familial Pancreatic Cancer, BRCA1 Mutation, BRCA2 Mutation, Lynch Syndrome, FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome, Hereditary Pancreatitis, Peutz-Jeghers Syndrome
Related terms Colorectal Neoplasms, Hereditary Nonpolyposis, Dysplastic Nevus Syndrome, Hereditary pancreatitis, Pancreatic carcinoma, familial, Peutz-Jeghers Syndrome
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov